Cedar Brook Financial Partners, LLC Edwards Lifesciences Corp Transaction History

Cedar Brook Financial Partners, LLC

$13.3 Million
Q2 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 12, 2024	SELL	$61.71 - $77.76 $261,958 - $330,091	-4,245 Reduced 58.08%	3,064 $233,000
Q3 2023 Oct 17, 2023	BUY	$69.28 - $93.38 $1,108 - $1,494	16 Added 0.22%	7,309 $506,000
Q2 2023 Jul 05, 2023	BUY	$81.41 - $94.33 $83,201 - $96,405	1,022 Added 16.3%	7,293 $687,000
Q1 2023 Apr 04, 2023	SELL	$74.26 - $84.51 $1,485 - $1,690	-20 Reduced 0.32%	6,271 $518,000
Q4 2022 Feb 01, 2023	SELL	$68.3 - $87.44 $1,775 - $2,273	-26 Reduced 0.41%	6,291 $469,000
Q3 2022 Jan 03, 2023	SELL	$82.37 - $107.29 $5,354 - $6,973	-65 Reduced 1.02%	6,317 $521,000
Q2 2022 Aug 12, 2022	BUY	$86.5 - $128.27 $51,294 - $76,064	593 Added 10.24%	6,382 $607,000
Q1 2022 Apr 06, 2022	BUY	$101.96 - $128.34 $611 - $770	6 Added 0.1%	5,789 $681,000
Q4 2021 Jan 27, 2022	BUY	$106.37 - $130.68 $1,595 - $1,960	15 Added 0.26%	5,783 $749,000
Q3 2021 Nov 01, 2021	SELL	$102.91 - $122.75 $1,543 - $1,841	-15 Reduced 0.26%	5,768 $653,000
Q2 2021 Aug 16, 2021	SELL	$83.84 - $104.76 $4,862 - $6,076	-58 Reduced 0.99%	5,783 $599,000
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $65,855 - $75,890	-837 Reduced 12.53%	5,841 $489,000
Q4 2020 Feb 12, 2021	SELL	$71.69 - $91.23 $73,553 - $93,601	-1,026 Reduced 13.32%	6,678 $609,000
Q3 2020 Nov 09, 2020	BUY	$67.19 - $87.44 $2,687 - $3,497	40 Added 0.52%	7,704 $614,000
Q2 2020 Aug 05, 2020	BUY	$57.54 - $76.95 $295,467 - $395,138	5,135 Added 203.04%	7,664 $530,000
Q1 2020 May 07, 2020	BUY	$52.41 - $81.0 $2,987 - $4,617	57 Added 2.31%	2,529 $477,000
Q4 2019 Feb 06, 2020	BUY	$71.7 - $82.09 $2,079 - $2,380	29 Added 1.19%	2,472 $577,000
Q3 2019 Oct 24, 2019	BUY	$61.55 - $75.43 $3,200 - $3,922	52 Added 2.17%	2,443 $537,000
Q2 2019 Aug 06, 2019	BUY	$55.74 - $64.41 $1,059 - $1,223	19 Added 0.8%	2,391 $442,000
Q1 2019 May 08, 2019	BUY	$47.89 - $64.05 $34,193 - $45,731	714 Added 43.06%	2,372 $454,000
Q4 2018 Feb 11, 2019	BUY	$46.41 - $56.94 $76,947 - $94,406	1,658 New	1,658 $84,000

Others Institutions Holding EW

# of Institutions

1,417

Shares Held

469M

Call Options Held

2.44M

Put Options Held

2.65M

Vanguard Group Inc Valley Forge, PA

53.6M
Shares

$3.51 Billion
0.1% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.34 Billion
0.11% of portfolio
State Street Corp Boston, MA

26M
Shares

$1.7 Billion
0.11% of portfolio
Alliancebernstein L.P. New York, NY

20.3M
Shares

$1.33 Billion
0.68% of portfolio
Wellington Management Group LLP Boston, MA

16.9M
Shares

$1.11 Billion
0.29% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cedar Brook Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cedar Brook Financial Partners, LLC with notifications on news.

Account